Hif-1α supports cancer cell survival under hypoxic conditions through its activation of nuclear factor kappa B (NF-κB) as well as promotion of expression of ligands for program death receptor 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) [161]. Here, HIF1A is linked to cancer.